ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
+47.46%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$268M
AUM Growth
–
Cap. Flow
+$268M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
25%
Holding
94
New
94
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
IRD
Opus Genetics, Inc. Common Stock
IRD
|
$13.4M |
| 2 |
Curis
CRIS
|
$6.73M |
| 3 |
Ocular Therapeutix
OCUL
|
$6.28M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$6.24M |
| 5 |
Sutro Biopharma
STRO
|
$6.01M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.32% |
| 2 | Technology | 2.23% |
| 3 | Consumer Staples | 1.19% |
| 4 | Financials | 1.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IRD
1
Opus Genetics, Inc. Common Stock
IRD
$73.1M
| $13.4M | 5.01% | +2,068,530 | New | +$13.4M |
|
|
2
Curis
CRIS
$20.9M
| $6.73M | 2.51% | +822,009 | New | +$6.73M |
|
|
3
Ocular Therapeutix
OCUL
$2.12B
| $6.28M | 2.34% | +303,174 | New | +$6.28M |
|
|
ISEE
4
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.24M | 2.33% | +902,633 | New | +$6.24M |
|
|
5
Sutro Biopharma
STRO
$72.7M
| $6.01M | 2.24% | +276,719 | New | +$6.01M |
|
6
Syndax Pharmaceuticals
SNDX
$1.41B
| $5.86M | 2.19% | +263,596 | New | +$5.86M |
|
7
Genprex
GNPX
$5.49M
| $5.85M | 2.18% | +1,409,785 | New | +$5.85M |
|
8
Verastem
VSTM
$569M
| $5.82M | 2.17% | +2,731,974 | New | +$5.82M |
|
9
AnaptysBio
ANAB
$569M
| $5.62M | 2.1% | +261,209 | New | +$5.62M |
|
|
BLU
10
DELISTED
BELLUS Health Inc.
BLU
| $5.15M | 1.92% | +1,682,535 | New | +$5.15M |
|
11
Crinetics Pharmaceuticals
CRNX
$2.92B
| $5.11M | 1.91% | +361,930 | New | +$5.11M |
|
12
Insmed
INSM
$28.8B
| $4.95M | 1.85% | +148,743 | New | +$4.95M |
|
|
ITCI
13
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.88M | 1.82% | +153,348 | New | +$4.88M |
|
14
Cogent Biosciences
COGT
$1.69B
| $4.86M | 1.81% | +432,563 | New | +$4.86M |
|
15
Immatics
IMTX
$619M
| $4.38M | 1.63% | +405,670 | New | +$4.38M |
|
16
Nautilus Biotechnolgy
NAUT
$85.9M
| $4.34M | 1.62% | +400,000 | New | +$4.34M |
|
17
Myriad Genetics
MYGN
$593M
| $4.32M | 1.61% | +218,650 | New | +$4.32M |
|
|
EUCRU
18
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $4.26M | 1.59% | +400,000 | New | +$4.26M |
|
19
Celldex Therapeutics
CLDX
$1.47B
| $4.2M | 1.57% | +239,520 | New | +$4.2M |
|
20
Castle Biosciences
CSTL
$696M
| $4.16M | 1.55% | +61,991 | New | +$4.16M |
|
21
Illumina
ILMN
$15.8B
| $4.14M | 1.55% | +11,200 | New | +$4.14M |
|
22
Insulet
PODD
$23.9B
| $4.14M | 1.55% | +16,200 | New | +$4.14M |
|
23
Aurinia Pharmaceuticals
AUPH
$1.58B
| $4.07M | 1.52% | +293,917 | New | +$4.07M |
|
|
RCOR
24
DELISTED
Renovacor, Inc.
RCOR
| $3.97M | 1.48% | +388,845 | New | +$3.97M |
|
|
CNST
25
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $3.87M | 1.44% | +134,233 | New | +$3.87M |
|